Quarterly Result1 Aug 2025, 02:14 pm
Procter & Gamble Health Reports 20% Sales Growth in Q1 2025
AI Summary
Procter & Gamble Health Limited announced its Q1 2025 results with sales of ¥333 crores, a 20% increase from the previous year. The profit after tax (PAT) stood at ₹66 crores, up from ₹17 crores a year ago. The growth was driven by broad-based growth in domestic and export businesses. The company's strategy of focusing on a portfolio of quality, trusted, and highly recommended brands, superiority, constructive disruption, and an agile accountable organization is delivering balanced and sustainable growth results.
Key Highlights
- Sales up 20% to ¥333 crores in Q1 2025
- Profit After Tax (PAT) at ₹66 crores, up from ₹17 crores a year ago
- Growth driven by domestic and export businesses
- Company's strategy delivering balanced and sustainable growth results
- Procter & Gamble Health Limited is one of India’s largest VMS companies